Jason Aryeh's Net Worth
Jason Aryeh's net worth is estimated to be at least $21,197,041.67 as of 11/09/2024. CoreStreet's estimation of Jason Aryeh's net worth is based on their sale of stock and current holding of stock.
Jason Aryeh is Director at Ligand Pharmaceuticals Incorporated. They have executed at least 25 trades of stock as per SEC Form 4 filings. Their most recent trade was for 750 units of LGND stock on 09/03/2019. Their biggest sale was on 05/12/2017 when they sold 37,247 units of Ligand Pharmaceuticals Incorporated stock for $4,125,477.72. They typically trade 4 times per year.
Total value of insider buys:
- $1,274,160.24
Total value of insider sells:
- $19,922,881.43
Most recent insider trade:
- Sept. 3, 2019
Jason Aryeh's Insider Trading History
| Ligand Pharmaceuticals Incorporated | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 3, 2019 | Director | 750 | $87.01 | Buy | $65,257.50 |
Aug. 5, 2019 | Director | 746 | $90.01 | Buy | $67,147.46 |
July 31, 2019 | Director | 4,004 | $99.22 | Buy | $397,276.88 |
July 29, 2019 | Director | 250 | $106.01 | Buy | $26,502.50 |
June 11, 2019 | Director | 250 | $107.01 | Buy | $26,752.50 |
May 31, 2019 | Director | 1,000 | $109.51 | Buy | $109,510.00 |
May 29, 2019 | Director | 250 | $111.01 | Buy | $27,752.50 |
May 20, 2019 | Director | 250 | $112.01 | Buy | $28,002.50 |
May 14, 2019 | Director | 250 | $112.51 | Buy | $28,127.50 |
March 13, 2019 | Director | 202 | $112.51 | Buy | $22,727.02 |
March 9, 2018 | Director | 7,500 | $175.73 | Sell | $1,317,975.00 |
Feb. 23, 2018 | Director | 3,417 | $155.00 | Sell | $529,635.00 |
Aug. 23, 2017 | Director | 2,000 | $127.99 | Sell | $255,980.00 |
May 12, 2017 | Director | 37,247 | $110.76 | Sell | $4,125,477.72 |
Feb. 28, 2017 | Director | 32,000 | $106.35 | Sell | $3,403,200.00 |
Nov. 25, 2016 | Director | 18,479 | $107.31 | Sell | $1,982,981.49 |
Nov. 18, 2016 | Director | 6,330 | $105.28 | Sell | $666,422.40 |
May 6, 2016 | Director | 25,000 | $119.20 | Sell | $2,980,000.00 |
March 8, 2016 | Director | 6,129 | $101.18 | Sell | $620,132.22 |
June 4, 2015 | Director | 1,640 | $92.68 | Sell | $151,995.20 |
May 20, 2015 | Director | 9,240 | $87.34 | Sell | $807,021.60 |
Oct. 9, 2014 | Director | 11,000 | $42.99 | Buy | $472,890.00 |
Feb. 14, 2014 | Director | 40,320 | $76.44 | Sell | $3,082,060.80 |
| Merrimack Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 16, 2019 | Insider | 302 | $5.44 | Buy | $1,642.88 |
July 11, 2019 | Insider | 100 | $5.71 | Buy | $571.00 |